New hope for tough cancers: experimental drug enters human testing
NCT ID NCT07498725
Summary
This early-stage trial is testing a new drug called LRK-4189 to see if it is safe and might help treat advanced solid tumors, especially colorectal cancer. About 120 adults whose cancer has worsened despite treatment will take the drug alone or combined with standard chemotherapy for up to three years. The main goals are to find the safest dose and see if the drug shows any early signs of working against the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Antoine Lacassagne
Nice, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Western General Hospital
Edinburgh, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.